WWP1 E3 Ligase Targets LATS1 for Ubiquitin-Mediated Degradation in Breast Cancer Cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
WWP1 E3 Ligase Targets LATS1 for Ubiquitin-Mediated Degradation in Breast Cancer Cells
Authors
Keywords
Ubiquitin ligases, Cell proliferation, Immunoprecipitation, Breast cancer, Glutathione chromatography, Ligases, Ubiquitination, Carcinogenesis
Journal
PLoS One
Volume 8, Issue 4, Pages e61027
Publisher
Public Library of Science (PLoS)
Online
2013-04-04
DOI
10.1371/journal.pone.0061027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Hippo pathway—From top to bottom and everything in between
- (2012) Nicolas Tapon et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Hippo signaling in mammalian stem cells
- (2012) Annie M. Tremblay et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- A novel oncoprotein Pirh2: rising from the shadow of MDM2
- (2011) Zhihao Wang et al. CANCER SCIENCE
- SnapShot: The Hippo Signaling Pathway
- (2011) Caroline Badouel et al. CELL
- WWP1: a versatile ubiquitin E3 ligase in signaling and diseases
- (2011) Xu Zhi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- WW Domain-containing E3 Ubiquitin Protein Ligase 1 (WWP1) Delays Cellular Senescence by Promoting p27Kip1Degradation in Human Diploid Fibroblasts
- (2011) Xiaoxiao Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases
- (2011) Ling Xiao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability
- (2011) K. C. Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LATS tumor suppressor: A new governor of cellular homeostasis
- (2010) Stacy Visser et al. CELL CYCLE
- Hippo signaling at a glance
- (2010) Bin Zhao et al. JOURNAL OF CELL SCIENCE
- Modularity in the Hippo signaling pathway
- (2010) Marius Sudol et al. TRENDS IN BIOCHEMICAL SCIENCES
- The ubiquitin pathway: An emerging drug target in cancer therapy
- (2009) Sudharsana Rao Ande et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma
- (2009) Ceshi Chen et al. INTERNATIONAL JOURNAL OF CANCER
- WW domain containing E3 ubiquitin protein ligase 1 targets the full-length ErbB4 for ubiquitin-mediated degradation in breast cancer
- (2009) Y Li et al. ONCOGENE
- The HECT Family of E3 Ubiquitin Ligases: Multiple Players in Cancer Development
- (2008) Francesca Bernassola et al. CANCER CELL
- A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells
- (2008) S. W. Chan et al. CANCER RESEARCH
- Negative Regulation of YAP by LATS1 Underscores Evolutionary Conservation of the Drosophila Hippo Pathway
- (2008) J. Zhang et al. CANCER RESEARCH
- WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis
- (2008) Y Li et al. CELL DEATH AND DIFFERENTIATION
- Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
- (2008) Tsutomu Oka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumour-promoting activity of altered WWP1 expression in breast cancer and its utility as a prognostic indicator
- (2008) NS Nguyen Huu et al. JOURNAL OF PATHOLOGY
- TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway
- (2008) Q.-Y. Lei et al. MOLECULAR AND CELLULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started